Montezyd 4/Montezyd 5/Montezyd 10 Dosage/Direction for Use

It should be taken once daily. For asthma, the dose should be taken in the evening. For allergic rhinitis, the time of administration may be individualised to suit patient needs. Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening.
General Recommendations: The therapeutic effect of Montelukast tablets on parameters of asthma control occurs within one day. Montelukast tablets may be taken with or without food. Patients should be advised to continue taking Montelukast tablets while their asthma is controlled, as well as during periods of worsening asthma.
No dosage adjustment is necessary for paediatric patients, for the elderly, for patients with renal insufficiency, or mild‑to-moderate hepatic impairment, or for patients of either gender.
Montezyd 4/Montezyd 5: Paediatric Patients 6 to 14 Years of Age with Asthma and/or Allergic Rhinitis: The dosage for paediatric patients 6 to 14 years of age is one5 mg chewable tablet daily.
Paediatric Patients 2 to 5 Years of Age with Asthma and/or Allergic Rhinitis: The dosage for paediatric patients 2 to 5 years of age is one 4 mg chewable tablet daily.
Montezyd 10: Adults 15 Years of Age and Older with Asthma and/or Allergic Rhinitis: The dosage for adults 15 years of age and older is one 10 mg tablet daily.
Therapy with Montelukast in Relation to Other Treatments for Asthma: Montelukast can be added to a patient's existing treatment regimen.
Reduction in Concomitant Therapy: Bronchodilator Treatments: It can be added to the treatment regimen of patients who are not adequately controlled on bronchodilator alone. When a clinical response is evident (usually after the first dose), the patient's bronchodilator therapy can be reduced as tolerated.
Inhaled Corticosteroids: Treatment with Montelukast provides additional clinical benefit to patients treated with inhaled corticosteroids. A reduction in the corticosteroid dose can be made as tolerated. The dose should be reduced gradually with medical supervision. In some patients, the dose of inhaled corticosteroids can be tapered off completely.
Montelukast should not be abruptly substituted for inhaled corticosteroids.
Oral Corticosteroids: Limited data suggest that Montelukast may provide additional clinical benefit in patients with oral corticosteroids.